Ivonescimab First-Line Biliary Tract Cancer Phase III Overall Survival Data Selected as ESMO Late-Breaking Abstract; Nearly 30 Akeso Studies to Be Presented at ESMO 2026
HONG KONG, Sept. 22, 2026 /PRNewswire/ — Akeso, Inc. (9926.HK) ("Akeso" or…
ESENTIA Announces the Execution of an Agreement to Acquire the Guadalajara-Manzanillo Natural Gas Pipeline System, Connecting Existing System to the Port of Manzanillo
MEXICO CITY, Sept. 22, 2026 /PRNewswire/ — ESENTIA Energy Development, S.A.B. de…